Related Experiment Videos
Unstable angina. Strategies to minimize myocardial injury
L M Blake-Inada1, N Goldschlager
1Department of Medicine, University of California, San Francisco, School of Medicine, USA.
Insights
Treatment for unstable angina focuses on pain relief and preventing heart attacks. Early intervention includes aspirin, heparin, and beta blockers, with thrombolysis for specific cases, but long-term lifestyle changes are crucial.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Unstable angina requires prompt management to prevent myocardial infarction.
- Early identification of rapid angina progression is key.
Purpose of the Study:
- To outline optimal treatment strategies for unstable angina.
- To differentiate between acute interventions and long-term management.
Main Methods:
- Review of current guidelines and evidence for unstable angina treatment.
- Analysis of indications for medical therapy, thrombolysis, and revascularization.
Main Results:
- Initial treatment involves aspirin, heparin, intravenous nitrates, and beta blockers.
- Thrombolytic agents are reserved for specific ischemic evidence.
- Percutaneous transluminal coronary angioplasty or coronary artery bypass grafting considered for refractory cases.
Conclusions:
- Aggressive medical therapy is the cornerstone of unstable angina management.
- High-technology interventions are adjuncts, not replacements for lifestyle modification and long-term care.
- Risk-factor modification and daily aspirin are essential for long-term cardiac health.
Abstract:
The primary goals in treatment of unstable angina are to relieve pain and prevent or limit myocardial infarction or ischemia. Patients with distinct, rapid progression of their usual angina pattern should be admitted to a coronary care unit and given heparin and intravenous nitrates as well as aspirin. Cardioselective beta blockers should also be administered when there are no contraindications. Intravenous thrombolytic agents are indicated in patients with objective evidence of ischemia who fit criteria for this therapy. However, thrombolysis is not advocated for routine treatment of unstable angina. Percutaneous transluminal coronary angioplasty or coronary artery bypass grafting should be considered--depending on the location, age, and morphology of the culprit lesion and the degree of left ventricular dysfunction--in patients who have refractory or recurrent ischemia despite aggressive medical therapy. However, in general, high-technology interventions are not a substitute for long-term regimens, such as risk-factor and lifestyle modification, daily aspirin, and pharmacologic therapies aimed at maximizing cardiac function.